LG 101506
Alternative Names: LG 100754; LG 101506 FALatest Information Update: 11 Aug 2006
At a glance
- Originator Eli Lilly and Company; Ligand Pharmaceuticals
- Class Phenyl ethers; Small molecules; Unsaturated fatty acids
- Mechanism of Action Peroxisome proliferator-activated receptor modulators; Retinoid X receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Obesity; Type 2 diabetes mellitus
Most Recent Events
- 11 Aug 2006 No development reported - Preclinical for Obesity in USA (unspecified route)
- 11 Aug 2006 No development reported - Preclinical for Type-2 diabetes mellitus in USA (unspecified route)
- 14 May 2003 Ligand and Eli Lilly have agreed to a second extention of their collaboration